Blog
RSS FeedPosted by Michael Wonder on 06 Mar 2020
Girl loses High Court battle over NICE review of BioMarin’s phenylketonuria drug
5 March 2020 - An 11-year-old girl with the rare disease phenylketonuria has lost a legal battle in the High ...
Posted by Michael Wonder on 22 Feb 2020
UK deal over inclisiran
18 February 2020 - Government’s public enthusiasm looks premature given the lack of available data ...
Posted by Michael Wonder on 22 Feb 2020
Health ministers condemn Novartis lottery for Zolgensma, the world’s most expensive drug
12 February 2020 - Novartis has held the first draw to choose four babies who will receive its one-shot treatment ...
Posted by Michael Wonder on 30 Jan 2020
Brexit D-Day
31 January 2020 - After more than three years of Brexit talks, deals and political wrangling, the United Kingdom will officially ...
Posted by Michael Wonder on 29 Jan 2020
Cancer patients facing delays in getting ‘innovative’ drugs
29 January 2020 - A new analysis report has found that most innovative cancer drugs face delays in reaching patients. ...
Posted by Michael Wonder on 23 Jan 2020
Woman denied cancer drug on NHS which could extend her life because of where she lives
22 January 2020 - Ann, 64, can't get the drug she needs to survive because it's not available on the NHS ...
Posted by Michael Wonder on 16 Jan 2020
Breast cancer patients to have further NICE approved drug combination option on Cancer Drugs Fund
15 January 2020 - Another potentially life-extending drug combination for some people with advanced breast cancer will now be available on ...
Posted by Michael Wonder on 13 Jan 2020
Novartis strikes deal with UK to provide cholesterol drug to high-risk patients
13 January 2020 - Pharmaceutical giant Novartis reached a deal with the U.K. to provide its late-stage cholesterol drug, inclisiran, to ...
Posted by Michael Wonder on 14 Nov 2019
NICE ‘OK’ for Sativex in MS
14 November 2019 - NICE has recommended Bayer’s Sativex (delta-9 tetrahydrocannabinol cannabidiol), for spasticity in people with multiple sclerosis. ...
Posted by Michael Wonder on 11 Nov 2019
Medical cannabis ruled out for chronic pain by NHS drug watchdog in decision branded 'devastating'
11 November 2019 - Cannabis should not be prescribed for chronic pain, the NHS funding watchdog has ruled, in a ...
Posted by Michael Wonder on 24 Oct 2019
NHSE signs ‘definitive’ agreement for Vertex CF drugs
24 October 2019 - NHS England has announced a definitive agreement with Vertex Pharmaceuticals to make all three of their ...
Posted by Michael Wonder on 23 Oct 2019
Cystic fibrosis: NHS patients in England to get life-transforming drugs 'within weeks'
23 October 2019 - Orkambi and Symkevi have been shown to radically the improve lung function of sufferers - but were ...
Posted by Michael Wonder on 03 Oct 2019
ABPI details Brexit plans at PIPA conference
3 October 2019 - The Association of the British Pharmaceutical Industry announced its latest Brexit contingency plans at the PIPA ...
Posted by Michael Wonder on 28 Sep 2019
AveXis rules out EU compassionate use of SMA gene therapy, says Biogen option is available
27 September 2019 - Novartis’ AveXis unit has given its reasons for refusing to supply its spinal muscular atrophy gene ...
Posted by Michael Wonder on 27 Sep 2019
With Brexit looming, what does the future hold for UK biosimilars?
26 September 2019 - If and when the United Kingdom leaves the European Union, the Medicines and Healthcare Products Regulatory Agency ...